1-3 of 3
Jose Pablo Vargas Viveros
Close
Sort by
Journal Articles

Hyperimmunoglobulin E Syndrome (HIES) Treated with Thalidomide Plus Dexamethasone with Encouraging Results

Rafael Hurtado Monroy, MD, Pamela Denisse Soberanis Pina, MD, Juan Jose Calva Mercado, Jose Pablo Vargas Viveros, Catalina Romo Aguirre
Journal: Blood
Blood (2017) 130 (Supplement 1): 4822.
https://doi.org/10.1182/blood.V130.Suppl_1.4822.4822
Published: 2017
Journal Articles

An Individual Patient Supply Program for Ruxolitinib for the Treatment of Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF).

Giovanni Barosi, MD, Mohan Agarwal, MD, MNAMS, Sonja Zweegman, MD, PhD, Wolfgang Willenbacher, MD, Sima Pakstyte, MD, Reinier Raymakers, MD, PhD, Nathan Cantoni, MD, Ankur Modi, Mahmudul Khan, PhD, Jose Ricardo Perez, MD, Hans Hasselbalch, MD, Jose Pablo Vargas Viveros, MD, Camila C.G. Linardi, MD, PhD, Heinz Gisslinger, MD, Adelmo Henrique Daumas Gabriel, MD, Francesca Palandri, David Lavie, MD, Claire N Harrison, DM FRCP FRCPath
Journal: Blood
Blood (2012) 120 (21): 2844.
https://doi.org/10.1182/blood.V120.21.2844.2844
Published: 2012
Journal Articles

Chronic Myeloid Leukemia Philadelphia Chromosome Positive (CML Ph+) with Imatinib (IM) Intolerance or Resistant Disease. Response to Thalidomide (TALI) Treatment. Preliminary Report of a Serial of Cases with Encouraging Results

Rafael Hurtado, MD, Jose Pablo Vargas Viveros, MD, Carrillo Muñoz Silvia, RN, Judith Cruz-Velazquez, Myrna Candelaria, MD, PhD, Eduardo Cervera, MD
Journal: Blood
Blood (2012) 120 (21): 1689.
https://doi.org/10.1182/blood.V120.21.1689.1689
Published: 2012